These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 10344524

  • 1. Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidine.
    Bock C, Niederhoffer N, Szabo B.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):262-71. PubMed ID: 10344524
    [Abstract] [Full Text] [Related]

  • 2. Role of I1 imidazoline receptors in the sympathoinhibition produced by intracisternally administered rilmenidine and moxonidine.
    Szabo B, Urban R.
    Arzneimittelforschung; 1997 Sep; 47(9):1009-15. PubMed ID: 9342413
    [Abstract] [Full Text] [Related]

  • 3. Mechanism of sympathoinhibition by imidazolines.
    Szabo B, Urban R.
    Ann N Y Acad Sci; 1995 Jul 12; 763():552-65. PubMed ID: 7677373
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of the sympathoinhibition produced by the clonidine-like drugs rilmenidine and moxonidine.
    Szabo B, Bock C, Nordheim U, Niederhoffer N.
    Ann N Y Acad Sci; 1999 Jun 21; 881():253-64. PubMed ID: 10415923
    [Abstract] [Full Text] [Related]

  • 5. Role of imidazoline receptors in the cardiovascular actions of moxonidine, rilmenidine and clonidine in conscious rabbits.
    Chan CK, Sannajust F, Head GA.
    J Pharmacol Exp Ther; 1996 Feb 21; 276(2):411-20. PubMed ID: 8632304
    [Abstract] [Full Text] [Related]

  • 6. Relative importance of central imidazoline receptors for the antihypertensive effects of moxonidine and rilmenidine.
    Chan CK, Head GA.
    J Hypertens; 1996 Jul 21; 14(7):855-64. PubMed ID: 8818924
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Importance of imidazoline-preferring receptors in the cardiovascular actions of chronically administered moxonidine, rilmenidine and clonidine in conscious rabbits.
    Parkin ML, Godwin SJ, Head GA.
    J Hypertens; 2003 Jan 21; 21(1):167-78. PubMed ID: 12544449
    [Abstract] [Full Text] [Related]

  • 9. No evidence for functional imidazoline receptors on locus coeruleus neurons.
    Szabo B, Fröhlich R, Illes P.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr 21; 353(5):557-63. PubMed ID: 8740150
    [Abstract] [Full Text] [Related]

  • 10. Neuronal norepinephrine responses of the rostral ventrolateral medulla and nucleus tractus solitarius neurons distinguish the I1- from the alpha2-receptor-mediated hypotension in conscious SHRs.
    Li G, Wang X, Abdel-Rahman AA.
    J Cardiovasc Pharmacol; 2005 Jul 21; 46(1):52-62. PubMed ID: 15965355
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Importance of imidazoline receptors in the cardiovascular actions of centrally acting antihypertensive agents.
    Head GA.
    Ann N Y Acad Sci; 1995 Jul 12; 763():531-40. PubMed ID: 7677371
    [Abstract] [Full Text] [Related]

  • 13. Involvement of imidazoline receptors in the baroreflex effects of rilmenidine in conscious rabbits.
    Head GA, Burke SL, Sannajust FJ.
    J Hypertens; 2001 Sep 12; 19(9):1615-24. PubMed ID: 11564982
    [Abstract] [Full Text] [Related]

  • 14. Involvement of alpha 2-adrenoceptors in the cardiovascular effects of moxonidine.
    Urban R, Szabo B, Starke K.
    Eur J Pharmacol; 1995 Aug 25; 282(1-3):19-28. PubMed ID: 7498275
    [Abstract] [Full Text] [Related]

  • 15. Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts.
    Mukaddam-Daher S, Menaouar A, Gutkowska J.
    Eur J Pharmacol; 2006 Jul 10; 541(1-2):73-9. PubMed ID: 16774751
    [Abstract] [Full Text] [Related]

  • 16. Rilmenidine-induced ocular hypotension: role of imidazoline1 and alpha 2 receptors.
    Chu TC, Wong W, Gluchowski C, Hughes BW, Potter DE.
    Curr Eye Res; 1996 Sep 10; 15(9):943-50. PubMed ID: 8921215
    [Abstract] [Full Text] [Related]

  • 17. Site and receptors involved in the sympathoinhibitory actions of rilmenidine.
    Head GA, Burke SL, Chan CK.
    J Hypertens Suppl; 1998 Aug 10; 16(3):S7-12. PubMed ID: 9747904
    [Abstract] [Full Text] [Related]

  • 18. Contribution of imidazoline receptors and alpha2-adrenoceptors in the rostral ventrolateral medulla to sympathetic baroreflex inhibition by systemic rilmenidine.
    Chan CK, Burke SL, Head GA.
    J Hypertens; 2007 Jan 10; 25(1):147-55. PubMed ID: 17143186
    [Abstract] [Full Text] [Related]

  • 19. Selective antihypertensive action of moxonidine is mediated mainly by I1-imidazoline receptors in the rostral ventrolateral medulla.
    Haxhiu MA, Dreshaj I, Schäfer SG, Ernsberger P.
    J Cardiovasc Pharmacol; 1994 Jan 10; 24 Suppl 1():S1-8. PubMed ID: 7533221
    [Abstract] [Full Text] [Related]

  • 20. Central imidazoline receptors and centrally acting anti-hypertensive agents.
    Head GA, Burke SL, Chan CK.
    Clin Exp Hypertens; 1997 Jan 10; 19(5-6):591-605. PubMed ID: 9247741
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.